EP2462973A2 — Nasal delivery devices
Assigned to Optinose AS · Expires 2012-06-13 · 14y expired
What this patent protects
A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a body member (101; 201); a carrier (109; 209) which is supported by the body member (101; 201) and carries a plurality of substance-containing containers (C; B); a no…
USPTO Abstract
A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a body member (101; 201); a carrier (109; 209) which is supported by the body member (101; 201) and carries a plurality of substance-containing containers (C; B); a nosepiece unit (119; 219) including a nosepiece (147; 247) for fitting to a nasal cavity of the subject; a mouthpiece unit (121; 221) including a mouthpiece (167; 249) through which the subject in use exhales; and an actuating mechanism which is operative, in each operation, to open a plurality of the substance-containing containers (C; B), and including a valve unit (169; 251) for fluidly connecting the mouthpiece (167; 249) to a respective one of the opened substance-containing containers (C; B) in successive exhalation cycles.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.